Sign in
4

Changes in Ownership

Arcturus Therapeutics Holdings Inc. Filed Acc 0001209191-20-031641

Director acquired 600,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ultragenyx Pharmaceutical Inc. Director 2020-05-20 Option exercise +600,000 $16.00 $9,600,000 3,000,000 D
Derivatives
Ultragenyx Pharmaceutical Inc. Director 2020-05-20 Option exercise · Option (Right to Buy) −600,000 0 D
Loading xslF345X03/doc4.xml…